ALA -PDT for the Treatment of Cutaneous Pseudolymphoma: A Case Report

June 2010 | Volume 9 | Issue 6 | Case Report | 688 | Copyright © 2010

Jenna O’Neill MD, Sari Fien MD, Nathalie C. Zeitouni MDC M FRCPC


Cutaneous pseudolymphoma (CPL) is a benign skin condition that may cause cosmetic disfigurement, severe itch and, albeit rarely, transformation to malignant lymphoma. The usual treatment modalities for CPL have been associated with adverse effects including skin atrophy and scarring. This article reports the case of a patient with CPL on the cheek, which was treated with 5-aminolevulinic acid photodynamic therapy (ALA-PDT). Clinically significant improvement in lesion size and symptoms was noted, with few side effects. Controlled trials and long-term monitoring are warranted to further explore this treatment modality for CPL.

Purchase Original Article

Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.

Download the original manuscript as it was published in the JDD.

Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.

To get access to JDD's full-text articles and archives, upgrade here.

Save an unformatted copy of this article for on-screen viewing.

Print the full-text of article as it appears on the JDD site.

→ proceed | ↑ close

Related Articles